Evarrest European Union - English - EMA (European Medicines Agency)

evarrest

omrix biopharmaceuticals n. v. - human fibrinogen, human thrombin - hemostasis - local hemostatics - supportive treatment in adult surgery where standard surgical techniques are insufficient (see section 5.1):- for improvement of haemostasis.

Evicel European Union - English - EMA (European Medicines Agency)

evicel

omrix biopharmaceuticals n. v. - human fibrinogen, human thrombin - hemostasis, surgical - antihemorrhagics - evicel is used as supportive treatment in surgery where standard surgical techniques are insufficient, for improvement of haemostasis.evicel is also indicated as suture support for haemostasis in vascular surgery.

TACHOSIL human fibrinogen 5.5mg/square cm and human thrombin 2.0IU/square cm medicated sponge blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

tachosil human fibrinogen 5.5mg/square cm and human thrombin 2.0iu/square cm medicated sponge blister pack

ksj pharmatech - human thrombin, quantity: 2 iu/cm2; fibrinogen, quantity: 5.5 mg/cm2 - sponge, medicated - excipient ingredients: sodium chloride; riboflavin; collagen; sodium citrate dihydrate; arginine hydrochloride; albumin - ? tachosil? is indicated as an adjunct to haemostasis during surgery when control of bleeding by standard surgical techniques is ineffective or impractical.

RAPLIXA fibrinogen human and thrombin powder United States - English - NLM (National Library of Medicine)

raplixa fibrinogen human and thrombin powder

profibrix bv - fibrinogen human (unii: n94833051k) (fibrinogen human - unii:n94833051k) - fibrinogen human 79 mg in 1 g

VeraSeal solutions for sealant 2 mL (Human fibrinogen 80 mg/mL syringe 1 mL / Human thrombin 500 IU/mL syringe 1 mL) Australia - English - Department of Health (Therapeutic Goods Administration)

veraseal solutions for sealant 2 ml (human fibrinogen 80 mg/ml syringe 1 ml / human thrombin 500 iu/ml syringe 1 ml)

grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.

VeraSeal solutions for sealant 10 mL (Human fibrinogen 80 mg/mL syringe 5 ml / Human thrombin 500 IU/mL syringe 5 ml) Australia - English - Department of Health (Therapeutic Goods Administration)

veraseal solutions for sealant 10 ml (human fibrinogen 80 mg/ml syringe 5 ml / human thrombin 500 iu/ml syringe 5 ml)

grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.

VeraSeal solutions for sealant 4 mL (Human fibrinogen 80 mg/mL syringe 2 ml / Human thrombin 500 IU/mL syringe 2 ml) Australia - English - Department of Health (Therapeutic Goods Administration)

veraseal solutions for sealant 4 ml (human fibrinogen 80 mg/ml syringe 2 ml / human thrombin 500 iu/ml syringe 2 ml)

grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.

VeraSeal solutions for sealant 6 mL (Human fibrinogen 80 mg/mL syringe 3 ml / Human thrombin 500 IU/mL syringe 3 ml) Australia - English - Department of Health (Therapeutic Goods Administration)

veraseal solutions for sealant 6 ml (human fibrinogen 80 mg/ml syringe 3 ml / human thrombin 500 iu/ml syringe 3 ml)

grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.

TISSEEL Ready to use Solution for Sealant (2ml vial) Malta - English - Medicines Authority

tisseel ready to use solution for sealant (2ml vial)

baxter healthcare limited - calcium chloride; aprotinin; fibrinogen, human; thrombin, human - solution for sealant - calcium chloride 40 µmole/ml; aprotinin 3000 kiu/ml; fibrinogen, human 91 mg/ml; thrombin, human 500 iu/mg - antihemorrhagics

EVICEL FIBRIN SEALANT (HUMAN)- fibrinogen human and thrombin human kit United States - English - NLM (National Library of Medicine)

evicel fibrin sealant (human)- fibrinogen human and thrombin human kit

ethicon inc - fibrinogen human (unii: n94833051k) (fibrinogen human - unii:n94833051k) - evicel® fibrin sealant (human) is indicated as an adjunct to hemostasis for use in patients undergoing surgery when control of bleeding by standard surgical techniques (such as suture, ligature, or cautery) is ineffective or impractical. do not use evicel®: - directly into the circulatory system. intravascular application of evicel® may result in life-threatening thromboembolic events [see warnings and precautions, (5.1) and adverse reactions, (6.2)]. - in individuals known to have anaphylactic or severe systemic reaction to human blood products [see adverse reactions (6.2)]. - for brisk arterial bleeding. - for spraying in endoscopic or laparoscopic procedures in those instances where the minimum recommended distance from the applicator tip to the target site cannot be ensured. [see dosage and administration (2.3)]. risk summary there are no data with evicel® use in pregnant women to inform a drug-associated risk. animal reproduction studies have not been conducted with evicel® . it is not known whether